UQCRH
gene geneOn this page
Also known as QCR6UQCR8
Summary
UQCRH (ubiquinol-cytochrome c reductase hinge protein, HGNC:12590) is a protein-coding gene on chromosome 1p33, encoding Cytochrome b-c1 complex subunit 6, mitochondrial (P07919). Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. It is a common-essential gene (DepMap: required in 100.0% of cancer cell lines).
Enables ubiquinol-cytochrome-c reductase activity. Predicted to be involved in mitochondrial electron transport, ubiquinol to cytochrome c. Located in mitochondrial inner membrane. Implicated in mitochondrial complex III deficiency.
Source: NCBI Gene 7388 — RefSeq curated summary.
At a glance
- Gene–disease (curated): mitochondrial complex III deficiency, nuclear type 11 (Moderate, GenCC) — +1 more curated relationship
- GWAS associations: 2
- Clinical variants (ClinVar): 24 total — 1 pathogenic
- Phenotypes (HPO): 15
- Cancer dependency (DepMap): dependent in 100.0% of screened cell lines (common-essential)
- MANE Select transcript:
NM_006004
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:12590 |
| Approved symbol | UQCRH |
| Name | ubiquinol-cytochrome c reductase hinge protein |
| Location | 1p33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | QCR6, UQCR8 |
| Ensembl gene | ENSG00000173660 |
| Ensembl biotype | protein_coding |
| OMIM | 613844 |
| Entrez | 7388 |
Gene structure
Transcript identifiers
Ensembl transcripts: 19 — 15 protein_coding, 2 retained_intron, 2 nonsense_mediated_decay
ENST00000311672, ENST00000460947, ENST00000486951, ENST00000489056, ENST00000496387, ENST00000851050, ENST00000866773, ENST00000866774, ENST00000911995, ENST00000911996, ENST00000911997, ENST00000911998, ENST00000911999, ENST00000912000, ENST00000912001, ENST00000949408, ENST00000949409, ENST00000949410, ENST00000949411
RefSeq mRNA: 3 — MANE Select: NM_006004
NM_001297565, NM_001297566, NM_006004
CCDS: CCDS30704
Canonical transcript exons
ENST00000311672 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001957839 | 46303698 | 46303820 |
| ENSE00003539381 | 46310155 | 46310316 |
| ENSE00003578919 | 46316552 | 46316776 |
| ENSE00003728681 | 46309101 | 46309127 |
Expression profiles
Bgee: expression breadth ubiquitous, 150 present calls, max score 99.90.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 293.6809 / max 4294.2803, expressed in 1824 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 2734 | 291.2181 | 1824 |
| 2733 | 2.4629 | 1150 |
Top tissues by expression
150 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| cerebellar vermis | UBERON:0004720 | 99.90 | gold quality |
| heart left ventricle | UBERON:0002084 | 99.74 | gold quality |
| apex of heart | UBERON:0002098 | 99.67 | gold quality |
| right atrium auricular region | UBERON:0006631 | 99.64 | gold quality |
| primary visual cortex | UBERON:0002436 | 99.63 | gold quality |
| heart | UBERON:0000948 | 99.62 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 99.62 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 99.59 | gold quality |
| prefrontal cortex | UBERON:0000451 | 99.58 | gold quality |
| frontal cortex | UBERON:0001870 | 99.56 | gold quality |
| frontal lobe | UBERON:0016525 | 99.56 | gold quality |
| cerebellar cortex | UBERON:0002129 | 99.55 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 99.55 | gold quality |
| cerebellum | UBERON:0002037 | 99.54 | gold quality |
| right frontal lobe | UBERON:0002810 | 99.54 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 99.54 | gold quality |
| cerebral cortex | UBERON:0000956 | 99.53 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 99.52 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 99.52 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 99.52 | gold quality |
| hypothalamus | UBERON:0001898 | 99.49 | gold quality |
| rectum | UBERON:0001052 | 99.48 | gold quality |
| nucleus accumbens | UBERON:0001882 | 99.47 | gold quality |
| telencephalon | UBERON:0001893 | 99.47 | gold quality |
| islet of Langerhans | UBERON:0000006 | 99.44 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 99.42 | gold quality |
| brain | UBERON:0000955 | 99.42 | gold quality |
| substantia nigra | UBERON:0002038 | 99.42 | gold quality |
| thymus | UBERON:0002370 | 99.42 | silver quality |
| monocyte | CL:0000576 | 99.41 | gold quality |
Single-cell (SCXA)
Detected in 15 experiment(s), a significant marker in 12.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-89232 | yes | 1389.14 |
| E-MTAB-10042 | yes | 1250.98 |
| E-MTAB-8410 | yes | 46.59 |
| E-MTAB-9467 | yes | 35.09 |
| E-MTAB-7316 | yes | 25.64 |
| E-CURD-122 | yes | 19.40 |
| E-HCAD-9 | yes | 17.50 |
| E-MTAB-9221 | yes | 16.13 |
| E-HCAD-10 | yes | 12.32 |
| E-GEOD-135922 | yes | 11.27 |
| E-HCAD-25 | yes | 9.76 |
| E-MTAB-10018 | no | 4231.77 |
| E-GEOD-125970 | no | 50.82 |
| E-MTAB-8271 | no | 10.46 |
| E-ANND-3 | no | 0.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
17 targeting UQCRH, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-4719 | 99.73 | 72.10 | 3329 |
| HSA-MIR-12124 | 99.68 | 69.17 | 2700 |
| HSA-MIR-582-5P | 99.47 | 70.79 | 2635 |
| HSA-MIR-376A-3P | 99.06 | 69.17 | 1128 |
| HSA-MIR-376B-3P | 99.06 | 69.17 | 1128 |
| HSA-MIR-4801 | 98.96 | 69.42 | 2096 |
| HSA-MIR-935 | 98.82 | 69.36 | 1072 |
| HSA-MIR-7155-5P | 98.65 | 66.14 | 1290 |
| HSA-MIR-4731-3P | 98.56 | 68.60 | 1860 |
| HSA-MIR-4317 | 98.49 | 67.09 | 987 |
| HSA-MIR-6819-5P | 97.96 | 66.59 | 1071 |
| HSA-MIR-6737-5P | 97.75 | 66.54 | 1044 |
| HSA-MIR-376C-3P | 97.63 | 68.88 | 1263 |
| HSA-MIR-6812-5P | 97.56 | 65.39 | 1059 |
| HSA-MIR-600 | 97.07 | 66.73 | 1259 |
| HSA-MIR-5579-5P | 96.32 | 68.54 | 730 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 100.0% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 6)
- These data provide preliminary evidence of the inactivation of UQCRH gene in cancer either by structural rearrangements or epigenetic mechanisms. (PMID:12881716)
- Results show that UQCRH is overexpressed in hepatocellular carcinoma. (PMID:28332314)
- UQCRH downregulation promotes Warburg effect in renal cell carcinoma cells. (PMID:32929120)
- Genome-wide analysis of DNA methylation identifies the apoptosis-related gene UQCRH as a tumor suppressor in renal cancer. (PMID:34133843)
- Characterising a homozygous two-exon deletion in UQCRH: comparing human and mouse phenotypes. (PMID:34750991)
- Association of abnormal NDUFB2 and UQCRH expression with venous thromboembolism in patients with liver cirrhosis. (PMID:38181234)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | uqcrh | ENSDARG00000059128 |
| mus_musculus | Uqcrh | ENSMUSG00000063882 |
| rattus_norvegicus | Uqcrh | ENSRNOG00000012550 |
| drosophila_melanogaster | UQCR-11L | FBGN0050354 |
| drosophila_melanogaster | UQCR-11 | FBGN0260008 |
Paralogs (1): UQCRHL (ENSG00000233954)
Protein
Protein identifiers
Cytochrome b-c1 complex subunit 6, mitochondrial — P07919 (reviewed: P07919)
Alternative names: Complex III subunit 6, Complex III subunit VIII, Cytochrome c1 non-heme 11 kDa protein, Mitochondrial hinge protein, Ubiquinol-cytochrome c reductase complex 11 kDa protein
All UniProt accessions (3): P07919, A0A087WTF2, A0A087X2B9
UniProt curated annotations — full annotation on UniProt →
Function. Component of the ubiquinol-cytochrome c oxidoreductase, a multisubunit transmembrane complex that is part of the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over the inner membrane that drives transmembrane transport and the ATP synthase. The cytochrome b-c1 complex catalyzes electron transfer from ubiquinol to cytochrome c, linking this redox reaction to translocation of protons across the mitochondrial inner membrane, with protons being carried across the membrane as hydrogens on the quinol. In the process called Q cycle, 2 protons are consumed from the matrix, 4 protons are released into the intermembrane space and 2 electrons are passed to cytochrome c.
Subunit / interactions. Component of the ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII), a multisubunit enzyme composed of 11 subunits. The complex is composed of 3 respiratory subunits cytochrome b, cytochrome c1 and Rieske protein UQCRFS1, 2 core protein subunits UQCRC1/QCR1 and UQCRC2/QCR2, and 6 low-molecular weight protein subunits UQCRH/QCR6, UQCRB/QCR7, UQCRQ/QCR8, UQCR10/QCR9, UQCR11/QCR10 and subunit 9, the cleavage product of Rieske protein UQCRFS1. The complex exists as an obligatory dimer and forms supercomplexes (SCs) in the inner mitochondrial membrane with NADH-ubiquinone oxidoreductase (complex I, CI) and cytochrome c oxidase (complex IV, CIV), resulting in different assemblies (supercomplex SCI(1)III(2)IV(1) and megacomplex MCI(2)III(2)IV(2)).
Subcellular location. Mitochondrion inner membrane.
Disease relevance. Mitochondrial complex III deficiency, nuclear type 11 (MC3DN11) [MIM:620137] A form of mitochondrial complex III deficiency, a disorder of the mitochondrial respiratory chain resulting in a highly variable phenotype depending on which tissues are affected. MC3DN11 is an autosomal recessive form characterized by recurrent episodes of severe lactic acidosis, hyperammonemia, hypoglycemia, and encephalopathy. The disease may be caused by variants affecting the gene represented in this entry.
Similarity. Belongs to the UQCRH/QCR6 family.
RefSeq proteins (3): NP_001284494, NP_001284495, NP_005995* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR003422 | Cyt_b-c1_6 | Family |
| IPR023184 | Ubol_cytC_Rdtase_hinge_dom | Domain |
| IPR036811 | Ubol_cytC_Rdtase_hinge_dom_sf | Homologous_superfamily |
Pfam: PF02320
UniProt features (15 total): helix 4, modified residue 2, disulfide bond 2, transit peptide 1, chain 1, turn 1, region of interest 1, compositionally biased region 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
5 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 9HZL | ELECTRON MICROSCOPY | 2.52 |
| 9CG3 | ELECTRON MICROSCOPY | 2.96 |
| 5XTE | ELECTRON MICROSCOPY | 3.4 |
| 5XTH | ELECTRON MICROSCOPY | 3.9 |
| 5XTI | ELECTRON MICROSCOPY | 17.4 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P07919-F1 | 87.91 | 0.69 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 42, 85
Disulfide bonds (2): 37–81, 53–67
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-611105 | Respiratory electron transport |
| R-HSA-9865881 | Complex III assembly |
MSigDB gene sets: 252 (showing top):
CCAWYNNGAAR_UNKNOWN, MODULE_151, GCM_NPM1, MORF_UBE2I, MORF_HDAC1, HSIAO_HOUSEKEEPING_GENES, TGACCTY_ERR1_Q2, YY1_Q6, GOBP_MONOATOMIC_CATION_TRANSPORT, GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY, GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_UBIQUINOL_TO_CYTOCHROME_C, GOBP_OXIDATIVE_PHOSPHORYLATION, GOBP_ELECTRON_TRANSPORT_CHAIN, MORF_BUB3, KEGG_HUNTINGTONS_DISEASE
GO Biological Process (5): oxidative phosphorylation (GO:0006119), mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122), aerobic respiration (GO:0009060), cellular respiration (GO:0045333), proton transmembrane transport (GO:1902600)
GO Molecular Function (2): quinol-cytochrome-c reductase activity (GO:0008121), protein binding (GO:0005515)
GO Cellular Component (5): mitochondrion (GO:0005739), mitochondrial inner membrane (GO:0005743), respiratory chain complex III (GO:0045275), respiratory chain complex (GO:0098803), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Aerobic respiration and respiratory electron transport | 1 |
| Respiratory electron transport | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| aerobic respiration | 1 |
| proton motive force-driven ATP synthesis | 1 |
| aerobic electron transport chain | 1 |
| mitochondrial ATP synthesis coupled electron transport | 1 |
| cellular respiration | 1 |
| energy derivation by oxidation of organic compounds | 1 |
| monoatomic cation transmembrane transport | 1 |
| electron transfer activity | 1 |
| proton transmembrane transporter activity | 1 |
| oxidoreduction-driven active transmembrane transporter activity | 1 |
| oxidoreductase activity, acting on diphenols and related substances as donors | 1 |
| active monoatomic ion transmembrane transporter activity | 1 |
| binding | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| organelle inner membrane | 1 |
| mitochondrial membrane | 1 |
| cytochrome complex | 1 |
| respiratory chain complex | 1 |
| transmembrane transporter complex | 1 |
| oxidoreductase complex | 1 |
| protein-containing complex | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1827 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| UQCRH | UQCR10 | Q9UDW1 | 947 |
| UQCRH | UQCRB | P14927 | 905 |
| UQCRH | UQCRC1 | P31930 | 902 |
| UQCRH | UQCRQ | O14949 | 884 |
| UQCRH | CYC1 | P08574 | 880 |
| UQCRH | UQCR11 | O14957 | 820 |
| UQCRH | COX4I1 | P13073 | 820 |
| UQCRH | UQCRC2 | P22695 | 800 |
| UQCRH | NDUFB7 | P17568 | 799 |
| UQCRH | COX4I2 | Q96KJ9 | 796 |
| UQCRH | UQCRFS1 | P47985 | 792 |
| UQCRH | COX5A | P20674 | 711 |
| UQCRH | NDUFB9 | Q9Y6M9 | 690 |
| UQCRH | MT-CYB | P00156 | 685 |
| UQCRH | COX7A2 | P14406 | 678 |
IntAct
99 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ARL8A | UQCRH | psi-mi:“MI:0915”(physical association) | 0.720 |
| UQCRH | ARL8A | psi-mi:“MI:0915”(physical association) | 0.720 |
| UQCRB | COX7A2L | psi-mi:“MI:0914”(association) | 0.640 |
| UQCRH | COX7A2L | psi-mi:“MI:0914”(association) | 0.640 |
| COQ5 | COQ9 | psi-mi:“MI:0914”(association) | 0.590 |
| ENTREP3 | UQCRH | psi-mi:“MI:0915”(physical association) | 0.560 |
| UQCRH | RNF24 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UQCRH | ENTREP3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RNF24 | UQCRH | psi-mi:“MI:0915”(physical association) | 0.560 |
| UQCRH | NDFIP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRRG1 | UQCRH | psi-mi:“MI:0915”(physical association) | 0.560 |
| UQCRH | NDFIP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| UQCRH | DCTN6 | psi-mi:“MI:0914”(association) | 0.530 |
| FAM131B | AURKA | psi-mi:“MI:0914”(association) | 0.530 |
| ERBB3 | SLC31A1 | psi-mi:“MI:0914”(association) | 0.530 |
| SLC39A4 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| PBXIP1 | GOLIM4 | psi-mi:“MI:0914”(association) | 0.530 |
| GSDME | SLC27A2 | psi-mi:“MI:0914”(association) | 0.530 |
| PEX19 | MYO1D | psi-mi:“MI:0914”(association) | 0.530 |
| SIRT3 | psi-mi:“MI:0915”(physical association) | 0.400 | |
| NPM1 | UQCRH | psi-mi:“MI:0915”(physical association) | 0.370 |
| NDUFA12 | NDUFS8 | psi-mi:“MI:0914”(association) | 0.350 |
| OTUB1 | psi-mi:“MI:0914”(association) | 0.350 | |
| OTUB1 | EPM2A | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (165): FAM189B (Two-hybrid), RNF24 (Two-hybrid), ARL8A (Two-hybrid), UQCRH (Affinity Capture-MS), UQCRH (Affinity Capture-MS), NDUFS4 (Co-fractionation), UQCRH (Co-fractionation), UQCRH (Co-fractionation), UQCRH (Affinity Capture-MS), UQCRH (Affinity Capture-MS), COX7A2L (Affinity Capture-MS), DOCK11 (Affinity Capture-MS), UQCRB (Affinity Capture-MS), PEX19 (Affinity Capture-MS), ACTR10 (Affinity Capture-MS)
ESM2 similar proteins: A0A096LP55, A0A1D8PJT8, A1L243, A1L3N6, A6H767, A9ULB4, P00126, P00429, P05067, P07919, P08592, P12023, P13805, P14854, P23025, P27088, P28656, P36233, P36378, P48504, P55209, P56277, P79307, P99028, Q0P451, Q0VBY0, Q15545, Q28CA1, Q28EB4, Q2HJG8, Q4R374, Q4R5A5, Q4U0Y4, Q53CG4, Q5IS80, Q5M9I5, Q5R4D4, Q5R7L9, Q5RCT0, Q64267
Diamond homologs: A0A096LP55, P00126, P07919, P48504, P99028, Q5M9I5, Q8SPH5, A0A1D8PJT8, Q0WWE3, Q1ZXP3, Q9SJV7
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| UQCRH | “form complex” | “CoQ-cytochrome c reductase-Mitochondrial respiratory chain complex III” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 110 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Respiratory electron transport | 9 | 11.0× | 6e-05 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| aerobic respiration | 6 | 15.5× | 2e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
24 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 1 |
| Likely pathogenic | 0 |
| Uncertain significance | 13 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1801224 | NM_006004.4(UQCRH):c.55-527_243+48del | Pathogenic |
SpliceAI
922 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:46303817:GGAG:G | donor_gain | 1.0000 |
| 1:46303818:GAG:G | donor_gain | 1.0000 |
| 1:46303818:GAGG:G | donor_gain | 1.0000 |
| 1:46303819:AGGT:A | donor_loss | 1.0000 |
| 1:46303821:GT:G | donor_loss | 1.0000 |
| 1:46303822:T:G | donor_loss | 1.0000 |
| 1:46310141:T:A | acceptor_gain | 1.0000 |
| 1:46310148:A:AG | acceptor_gain | 1.0000 |
| 1:46310149:C:G | acceptor_gain | 1.0000 |
| 1:46310150:A:AG | acceptor_gain | 1.0000 |
| 1:46310150:ATCAG:A | acceptor_gain | 1.0000 |
| 1:46310151:T:G | acceptor_gain | 1.0000 |
| 1:46310152:CAGG:C | acceptor_loss | 1.0000 |
| 1:46310152:CAGGA:C | acceptor_gain | 1.0000 |
| 1:46310153:A:AG | acceptor_gain | 1.0000 |
| 1:46310153:AG:A | acceptor_gain | 1.0000 |
| 1:46310154:G:GA | acceptor_gain | 1.0000 |
| 1:46310154:GG:G | acceptor_gain | 1.0000 |
| 1:46310154:GGA:G | acceptor_gain | 1.0000 |
| 1:46310154:GGAT:G | acceptor_gain | 1.0000 |
| 1:46310154:GGATC:G | acceptor_gain | 1.0000 |
| 1:46310278:G:GT | donor_gain | 1.0000 |
| 1:46310312:ATTGC:A | donor_gain | 1.0000 |
| 1:46310313:TTGC:T | donor_gain | 1.0000 |
| 1:46310314:TGC:T | donor_gain | 1.0000 |
| 1:46310314:TGCGT:T | donor_loss | 1.0000 |
| 1:46310315:GC:G | donor_gain | 1.0000 |
| 1:46310315:GCG:G | donor_gain | 1.0000 |
| 1:46310315:GCGTA:G | donor_loss | 1.0000 |
| 1:46310316:CG:C | donor_loss | 1.0000 |
AlphaMissense
599 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:46310230:T:A | C53S | 0.993 |
| 1:46310231:G:C | C53S | 0.993 |
| 1:46310272:T:A | C67S | 0.993 |
| 1:46310273:G:C | C67S | 0.993 |
| 1:46310231:G:A | C53Y | 0.991 |
| 1:46310273:G:A | C67Y | 0.991 |
| 1:46310274:C:G | C67W | 0.990 |
| 1:46310272:T:C | C67R | 0.988 |
| 1:46310308:G:C | D79H | 0.988 |
| 1:46310230:T:C | C53R | 0.987 |
| 1:46310297:T:C | L75S | 0.986 |
| 1:46310309:A:T | D79V | 0.986 |
| 1:46310231:G:T | C53F | 0.985 |
| 1:46310273:G:T | C67F | 0.985 |
| 1:46310182:T:A | C37S | 0.984 |
| 1:46310183:G:C | C37S | 0.984 |
| 1:46310294:T:C | F74S | 0.984 |
| 1:46310232:T:G | C53W | 0.983 |
| 1:46310302:G:C | A77P | 0.983 |
| 1:46310309:A:C | D79A | 0.983 |
| 1:46310293:T:C | F74L | 0.982 |
| 1:46310295:C:A | F74L | 0.982 |
| 1:46310295:C:G | F74L | 0.982 |
| 1:46310175:A:C | R34S | 0.981 |
| 1:46310175:A:T | R34S | 0.981 |
| 1:46310182:T:C | C37R | 0.981 |
| 1:46310183:G:A | C37Y | 0.981 |
| 1:46310285:T:C | L71P | 0.981 |
| 1:46310314:T:A | C81S | 0.980 |
| 1:46310315:G:C | C81S | 0.980 |
dbSNP variants (sampled 300 via entrez): RS1000106401 (1:46302431 C>A,G,T), RS1000258252 (1:46308499 G>A), RS1000709907 (1:46313514 A>T), RS1000833304 (1:46307535 T>A,G), RS1000882462 (1:46307195 C>T), RS1001004742 (1:46302306 C>G,T), RS1001034237 (1:46302015 A>C,G), RS1001162734 (1:46303267 G>A,T), RS1001309464 (1:46308886 G>A,C,T), RS1001393337 (1:46314993 C>T), RS1001580919 (1:46302619 G>A,C,T), RS1001821351 (1:46314770 T>C), RS1001822518 (1:46314090 G>GC), RS1001832453 (1:46313833 C>T), RS1002061056 (1:46307712 G>A,C)
Disease associations
OMIM: gene MIM:613844 | disease phenotypes: MIM:620137
GenCC curated gene-disease
| Disease | Classification | Inheritance |
|---|---|---|
| mitochondrial complex III deficiency, nuclear type 11 | Moderate | Autosomal recessive |
ClinGen Gene-Disease Validity (1)
Expert-panel classifications — Definitive > Strong > Moderate > Limited > Disputed > Refuted.
| Disease | Classification | Inheritance |
|---|---|---|
| mitochondrial disease | Limited | AR |
Mondo (1): mitochondrial complex III deficiency, nuclear type 11 (MONDO:0859321)
Orphanet (0):
HPO phenotypes
15 total (15 of 15 shown, HPO-id order):
| HPO | Term |
|---|---|
| HP:0000007 | Autosomal recessive inheritance |
| HP:0001289 | Confusion |
| HP:0001733 | Pancreatitis |
| HP:0001942 | Metabolic acidosis |
| HP:0001943 | Hypoglycemia |
| HP:0001945 | Fever |
| HP:0001987 | Hyperammonemia |
| HP:0002013 | Vomiting |
| HP:0002014 | Diarrhea |
| HP:0002027 | Abdominal pain |
| HP:0002151 | Increased circulating lactate concentration |
| HP:0002788 | Recurrent upper respiratory tract infections |
| HP:0008551 | Microtia |
| HP:0011463 | Childhood onset |
| HP:0011924 | Decreased activity of mitochondrial complex III |
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005951_37 | Body mass index | 8.000000e-10 |
| GCST012227_1399 | Hip circumference adjusted for BMI | 1.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004340 | body mass index |
| EFO:0008039 | BMI-adjusted hip circumference |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
42 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Copper | affects cotreatment, decreases expression, increases abundance, affects binding | 2 |
| Doxorubicin | increases expression, decreases expression | 2 |
| dicrotophos | decreases expression | 1 |
| bisphenol A | affects expression | 1 |
| arsenite | affects binding, increases reaction | 1 |
| sodium arsenite | decreases expression | 1 |
| zinc chromate | increases abundance, increases expression | 1 |
| ochratoxin A | increases expression | 1 |
| acipimox | increases expression | 1 |
| beta-methylcholine | affects expression | 1 |
| arsenic trichloride | decreases expression, increases abundance, affects cotreatment | 1 |
| chromium hexavalent ion | increases abundance, increases expression | 1 |
| CD 437 | decreases expression | 1 |
| chloropicrin | affects expression | 1 |
| K 7174 | decreases expression | 1 |
| 3-(4’-hydroxy-3’-adamantylbiphenyl-4-yl)acrylic acid | decreases expression | 1 |
| bisphenol AF | increases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression, increases expression | 1 |
| Zoledronic Acid | decreases expression | 1 |
| Arsenic Trioxide | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Arsenic | decreases expression, increases abundance, affects cotreatment | 1 |
| Atrazine | decreases expression | 1 |
| Bilirubin | decreases expression | 1 |
| Cadmium | increases abundance, increases expression | 1 |
| Disulfiram | affects binding, decreases expression | 1 |
| Fluorouracil | affects expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Isoniazid | increases expression | 1 |
| Ivermectin | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Associated diseases: mitochondrial complex III deficiency, nuclear type 11, mitochondrial disease
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): mitochondrial complex III deficiency, nuclear type 11